Exam (elaborations)
Pharmacology Final study guide Part 2 questions & answers latest updated.
Course
Penn Foster Veterinary Pharmacology
Institution
Penn Foster Veterinary Pharmacology
Pharmacology Final study guide Part 2 questions & answers latest updated.
[Show more]
Uploaded on
August 27, 2024
Number of pages
8
Written in
2024/2025
Type
Exam (elaborations)
Contains
Questions & answers
Institution
Penn Foster Veterinary Pharmacology
Course
Penn Foster Veterinary Pharmacology
$11.49
Also available in package deal from $30.49
100% satisfaction guarantee
Immediately available after payment
Both online and in PDF
No strings attached
Also available in package deal (1)
$ 128.89
$ 30.49
11 items
1. Exam (elaborations) - Pharmacology penn foster veterinary technician questions and answers latest update.
2. Exam (elaborations) - Pharmacology final study guide part 2 questions & answers latest updated.
3. Exam (elaborations) - Vet tech pharmacology final.
4. Exam (elaborations) - Penn foster pharmacology proctor exam practice questions & answers latest updated.
5. Exam (elaborations) - Penn foster pharmacology questions & answers.
6. Exam (elaborations) - Veterinary pharmacology 088125rr (pennfoster exam questions & answers)
7. Exam (elaborations) - Pharmacology penn foster veterinary technician with correct answers.
8. Exam (elaborations) - Penn foster pharmacology proctor exam practice.
9. Exam (elaborations) - Veterinary pharmacology final exam.
10. Exam (elaborations) - Veterinary pharmacology-final exam review questions & answers.
11. Exam (elaborations) - Penn foster veterinary pharmacology final exam questions & answers.
Show more
Pharmacology Final study guide Part 2
questions & answers latest updated
Why nare neuthanasia nsolutions nthat ncontain nonly npentobarbital nclassified nas nClass
nII ncontrolled nsubstances, nwhereas nthose nthat ncontain npentobarbital nand nother
nsubstances nare nclassified nas nClass nIII ncontrolled nsubstances? n- nANS-some
npentobarbital neuthanasia nagents nhave na nred ndye nadded nto ndistinguish nthem nfrom
npentobarbital nagents nthat nmay nbe nused nfor nanesthesia. nBecause nthese nagents
nare neasily nidentified nas neuthanasia nagents, nthey nhave nless npotential nfor nabuse
What nclass nof ndrug nis nbutorphanol ntartrate? n- nANS-Synthethic nopiate,
nagonist/antagonist nwith nsignificant nantitussive nactivity. nAlso nused nas na
npreanesthetic n& nananalgeisic. nClass nIV nControlled nSubstances
Pharmacologists nclassify nantiarrhythmic ndrugs ninto nwhat nfour nbasic ncategories? n-
nANS--Class nIA nincludes nquinidine, nprocainamide, n& nothers n
-Class nIB nincludes nlidocaine, ntocainide,& nmexiletine n
-Class nIC nincludes nflecainide n& nencainide n
-Class nII nincludes nthe nbeta-adrenergic nblockers n(propranolol) n
-Class nIII nincludes nbretylium n& namiodarone n
-Class nIV nincludes nthe ncalcium nchannel nblockers n(verapamil, nnifedipine,
namlodipine, nand ndiltiazem)
List nsix ncategories nof nantiarrhythmic ndrugs nand ngive nan nexample nof neach n- nANS-•
nClass nIA-quinidine n
• nClass nIB-Lidocaine n
• nClass nIC-flecainide n
• nClass nII-propanolol
• nClass nIII-bretylium n
• nClass nIV- ndiltiazam
Codeine nis nclassified nin nwhat ncategory nof ncontrolled nsubstances n- nANS-Schedule
nV(5). nOpiate nagonist nthat nis nused nas nan nantitussive nin nhuman-label ncombination
nproducts
Drug nproducts nwith ncodeine nalone nare nin nwhat nschedule nof ncontolled nsubstance n-
nANS-Class nII(2)
Codeine nwith naspirin nor nacetaminophen nis___? n- nANS-C-III n(3), n(Class nIII)
, Codeine nsyrups nare? n- nANS-C-III n(3), n(Class nIII n(3)), nor nC-V(5) n(Class nV); nby
nstate
Intramuscular nroute n- nANS-injects nmedication ndirectly ninto nthe nmuscle.There, nblood
nvessels ncan nrapidly nabsorb nthe nmedication nand ntransfer nit nto nother nparts nof nthe
nbody. nThis nmethod nof nadministration nis nvery nfast nand nallows nfor nthe neffects nof
nmedication nto nrapidly noccur. nIt ncan, nhowever, nbe naffected nby npoor ncirculation n(as
nin nshock) nand nalso nhas na nmuch nhigher ncomplication nrate nthan nthe noral nor
nsublingual nroutes. nThis nroute ntypically nuses na nneedle, nas nin nan nauto-injector, nto
ndeliver nthe nmedication.
An narsenic ncompound nadministered nby ndeep nIM ninjection nin nthe nlumbar nregion nis
n__________. n- nANS-melarsomine ndihydrochloride
Most ndrug nexcretion noccurs nvia? n- nANS-kidneys
Why nis nLasix nsometimes ncalled na nloop ndiuretic? n- nANS-Lasix nis ncalled na nloop
ndiuretic nbecause nit ninhibits nreabsorption nof nsodium nin nthe nloops nof nHenle
What nis nactivated ncharcoal nused nfor? n- nANS-To nprevent nor nreduce nthe nsystemic
nabsorption nof ningested ndrugs nor ntoxins
Activated ncharcoal nis neffective nin nremoving nlead nfrom nthe nbody. nTrue nor nFalse n-
nANS-False
After nactivated ncharcoal nis nadministered, nno nother noral ntherapeutic nagents nshould
nbe nadministered nwithin n3 nhours. nTrue nor nFalse n- nANS-True
Naloxone nreverses nthe neffects nof nbutorphanol, npentazocine, nand nnalbuphine. n-
nANS-True
Name nfour ndrugs nthat nnaloxone neffectively nreverses n- nANS-Oxymorphone,
nTorbugesic, nTalwin-V nand nNubian
_____is na nnarcotic nantagonist nused nfor nthe ntreatment, nprevention, nor ncontrol nof
nnarcotic ndepression. n- nANS-Naloxone
Naloxone(naloxone nHCI ninjection, nNarcan) n- nANS-is na npure nopioid nantagonist nthat
nis nchemically nsimilar nto noxymorphone, nwith nhigh naffinity nfor nmu nreceptors. nIt nhas
nno nagonist nactivity
Schirmer ntear ntest n- nANS--diagnostic ntest nusing na ngraded npaper nstrip nto nmeasure
ntear nproduction
- nThe nfirst ndiagnostic nprocedures nto nbe nemployed nso nthat ntear nevaluation nis
ncalculated ncorrectly